9410 Key West Avenue
Rockville, MD 20850
Sell Stats: On September 20, 2001, the Rule Breaker Portfolio sold 560 shares of Human Genome Sciences (Nasdaq: HGSI). The trade was done, pure and simply, for tax reasons. For the full rationale, see the sell report.
ACTION # STOCK PRICE COMS'N REC'D Sold 560 HGSI $31.76 $8 $17,777.01
ACTION # STOCK PRICE COMS'N REC'D Sold 590 HGSI $13.35 $8 $7,868.26
Buy Stats: On September 22, 2000, the Rule Breaker portfolio bought 280 shares of protein drug developer Human Genome Sciences. For more information on why this investment was made, please see the buy announcement.
ACTION # STOCK PRICE COMS'N TOT PAID Bought 280 HGSI $160.11 $8 $44,838.50
On October 29, 2001, after selling our holding for tax reasons (see sale stats above), we repurchased 590 shares and issued a new buy announcement.
ACTION # STOCK PRICE COMS'N TOT PAID Bought 590 HGSI $43.06 $8 $25,405.60